Genprex GNPX
NASDAQ GNPX
$2.56 -0.36 (-12.33%)
At close: Oct 1, 2026 · 4:00 PM EDT

Genprex (GNPX) Total Debt (2017 - 2018)

Updated

Genprex (GNPX) recorded Total Debt of $279,288 in Q1 2018, up 38.3% from the prior quarter.

Analysis

Genprex (GNPX) Total Debt (2017 - 2018) Analysis & Trends

At the end of FY2017, Genprex reported Total Debt of $201,890.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 49.04 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 70.82 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 53.91 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 37.49 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -111.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 57.30 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 26.25 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 63.19 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Genprex 1.48 Mn -40.66 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2018 279,288.00
Dec 31, 2017 201,890.00
API Access

Genprex Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=GNPX&period=max&api_key=YOUR_API_KEY